Galapagos NV
GLPG
#4960
Rank
ยฃ1.38 B
Marketcap
ยฃ20.67
Share price
0.00%
Change (1 day)
-0.65%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: ยฃ1.38 Billion

As of June 2026 Galapagos NV has a market cap of ยฃ1.38 Billion. This makes Galapagos NV the world's 4960th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ1.38 B-14.12%
2025ยฃ1.61 B12.74%
2024ยฃ1.43 B-31.82%
2023ยฃ2.10 B-12.94%
2022ยฃ2.41 B-10.76%
2021ยฃ2.70 B-43.03%
2020ยฃ4.75 B-53.89%
2019ยฃ10.30 B160.55%
2018ยฃ3.95 B11.27%
2017ยฃ3.55 B47.14%
2016ยฃ2.41 B45.19%
2015ยฃ1.66 B353.78%
2014ยฃ0.36 B-3.53%
2013ยฃ0.37 B8.67%
2012ยฃ0.34 B52.36%
2011ยฃ0.22 B-16.73%
2010ยฃ0.27 B74.96%
2009ยฃ0.15 B124.65%
2008ยฃ70.11 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ432.12 B 31,031.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ114.38 B 8,140.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ299.79 B 21,498.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ78.94 B 5,587.74%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ219.13 B 15,687.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ206.66 B 14,788.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ79.25 B 5,609.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
ยฃ68.58 M-95.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ30.05 B 2,065.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel